compound semaglutide going away 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA Ends Compounded GLP-1s: What

Neurochem Res

I want to be really clear that this is just what I'm doing for me, it's not a dosing recommendation, MOTS-c is research-use-only and your protocol is between you and your provider

Neuromolecular etiology of bipolar disorder: possible therapeutic targets of mood stabilizers

Better Cardiometabolic Health: GLP-1 medications can contribute to improvements in blood pressure, insulin sensitivity, and blood sugar control, which may help reduce the risk of conditions such as hypertension and type 2 diabetes

Due to the effect this has on nerves, people suffering from spinal stenosis can experience pain, tingling, numbness or even muscle weakness